Mandate

Vinge advises GE Real Estate in connection with sale of real estate portfolio to, and investment in, real estate fund

January 13, 2009

Vinge has advised GE Real Estate Sweden AB in connection with the sale of a real estate portfolio consisting of approximately 30 properties to the newly started Roxanne Fastighetsfond.

The properties are situated in 15 municipalities in Sweden and comprise approximately 230,000 square metres of lettable space.

GE Real Estate has also invested in Roxanne Fastighetsfond. Other investors in the fund include Folksam Mutual Property Insurance Society (Sw. Folksam ömsesidig sakförsäkring), KPA Pensionsförsäkring AB (publ), Kåpan Pensions Insurance Society (Sw. Kåpan Pensioner Försäkringsförening), Vattenfall Pensions Foundation (Sw.Vattenfalls Pensionsstiftelse) and the Swedish Foundation for Strategic Research.

In connection with the transaction, Roxanne Fastighetsfond has also executed a management agreement with GE Real Estate concerning management of the company’s investments.

Vinge’s team consisted of partners Mattias Schömer, Rikard Stenberg and Stefan de Hevesy together with associates Petter Alberts, Sara Axelsson, Caroline Gebauer, Henrik Fritz and Johan Norström.

Related

Vinge advises Axcel VI and Currentum in connection with the acquisition of Elprojekt Skandinavien

Vinge advises Axcel VI and the Currentum Group in connection with the acquisition of Elprojekt Skandinavien. The company provides complete electrical installations throughout Sweden, focusing on new construction of logistics properties, production facilities, residential buildings and office buildings. Elprojekt Skandinavien had a revenue of SEK 316 million in 2024.
June 23, 2025

Vinge advises Meribel Pharma Solutions

Vinge advises Meribel Pharma Solutions in connection with the sale of a production facility specialising in the manufacture of antibiotics to Apotek Produktion & Laboratorier AB ("APL").
June 23, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 232 million and restructuring of debt financing

Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue, through which Hansa raises gross proceeds of approx. SEK 232 million, and restructuring of debt financing. As part of such debt restructuring, Hansa has in conjunction with the directed share issue set-off debt corresponding to approximately USD 14.9 million of its total debt amount.
June 23, 2025